C3ORF31 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.215770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.674140E-02
Normal-vs-Stage2
1.563250E-01
Normal-vs-Stage3
7.479400E-03
Normal-vs-Stage4
7.797000E-01
Stage1-vs-Stage2
2.976200E-02
Stage1-vs-Stage3
8.158000E-03
Stage1-vs-Stage4
1.454440E-02
Stage2-vs-Stage3
3.124500E-03
Stage2-vs-Stage4
2.059400E-01
Stage3-vs-Stage4
3.464800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.096810E-01
Normal-vs-AfricanAmerican
1.773780E-01
Normal-vs-Asian
5.567200E-01
Caucasian-vs-AfricanAmerican
6.917600E-01
Caucasian-vs-Asian
1.147840E-01
AfricanAmerican-vs-Asian
2.612800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.566100E-02
Normal-vs-Female
1.734050E-01
Male-vs-Female
6.807800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.034600E-01
Normal-vs-Age(41-60Yrs)
2.385000E-01
Normal-vs-Age(61-80Yrs)
7.818100E-02
Normal-vs-Age(81-100Yrs)
1.833630E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.892200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.644800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.269000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.253370E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.469800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.146800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.227400E-01
Normal-vs-Daily Drinker
7.495600E-02
Normal-vs-Weekly Drinker
4.881600E-01
Normal-vs-Occasional Drinker
4.879600E-02
Normal-vs-Social Drinker
1.517410E-01
Non Drinker-vs-Daily Drinker
4.927400E-01
Non Drinker-vs-Weekly Drinker
5.940000E-01
Non Drinker-vs-Occasional Drinker
8.593000E-01
Non Drinker-vs-Social Drinker
7.355200E-01
Daily Drinker-vs-Weekly Drinker
2.910400E-01
Daily Drinker-vs-Occasional Drinker
5.422200E-01
Daily Drinker-vs-Social Drinker
2.787200E-01
Weekly Drinker-vs-Occasional Drinker
5.352600E-01
Weekly Drinker-vs-Social Drinker
8.083200E-01
Occasional Drinker-vs-Social Drinker
5.250400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.798400E-01
Normal-vs-Grade 2
8.648800E-01
Normal-vs-Grade 3
8.757800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.659700E-03
Grade 1-vs-Grade 3
5.038700E-03
Grade 1-vs-Grade 4
7.798400E-01
Grade 2-vs-Grade 3
6.927400E-01
Grade 2-vs-Grade 4
8.648800E-01
Grade 3-vs-Grade 4
8.757800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.544450E-01
Normal-vs-NonDiabetic
1.169600E-01
Diabetic-vs-NonDiabetic
9.859400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.866600E-01
Normal-vs-NoPancreatitis
1.281360E-01
Pancreatitis-vs-NoPancreatitis
8.232200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.223770E-01
Normal-vs-N1
1.429440E-01
N0-vs-N1
9.387000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.593600E-01
Normal-vs-TP53-NonMutant
2.336000E-01
TP53-Mutant-vs-TP53-NonMutant
2.966800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
